Jim Cramer Discussed 27 Stocks, Like Arm and Lockheed, and the Recent Market Sell-Off
In this article, we will look at the stocks Jim Cramer discussed on Mad Money, along with the recent sell-off in the market.
Astrazeneca Plc (AZN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Gotham Asset Management Joel Greenblatt | 2,868 | $565,627 | +38% | 0% |
| 2. | NWI Management Hari Hariharan | 25,000 | $4,930,000 | 0.28% | |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 4. | ADAR1 Capital Management Daniel Schneeberger | 0 | $0 | 0% | |
| 5. | Samjo Capital Andrew N. Wiener | 0 | $0 | 0% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $185.78 | 11,893 | $2,209,481.54 | 19,262 | 2026-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 145,297 | $28,655,474 | 18.6% | |
| 2. | 117,184 | $22,700,536 | 6.84% | |
| 3. | 62,728 | $12,371,216 | 0.14% | |
| 4. | 62,182 | $12,063,190 | 0.29% | |
| 5. | 51,161 | $10,089,972 | 0.05% |
News See All
AstraZeneca's (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
AstraZeneca PLC (NYSE:AZN) is one of the best stocks to buy now for long term growth. AstraZeneca PLC (NYSE:AZN) reported on May 29 that the global CARES Phase III clinical programme showed that treatment...
10 Best Stocks to Buy Now for Long Term Growth
On May 29, Andrew Slimmon, Senior Portfolio Manager at Morgan Stanley, appeared on CNBC’s 'Closing Bell' to talk about equity markets, whether investors should keep riding the tech winning streak, and...
CDT Equity Advances AstraZeneca PLC (AZN)'s AZD5904 Into PCT Patent Protection Stage
TheFly reported on May 6 that CDT Equity announced that AZD5904, a selective inhibitor of human myeloperoxidase originally licensed from AstraZeneca PLC (NYSE:AZN), has entered the Patent Cooperation ...
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
On April 30, Bloomberg reported that Steve Cohen resigned as president of Point72 Asset Management, and Harry Schwefel was appointed co-CIO.
10 Best Cancer Stocks to Buy for the Long Term
Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.
AstraZeneca PLC (NYSE:AZN) Q1 2026 Earnings Call Transcript
Operator: Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe, and good evening to those listening in Asia.
Strong Results and Improved Guidance Lifted AstraZeneca PLC (AZN)
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?
Is AZN a good stock to buy? We came across a bullish thesis on AstraZeneca PLC on South Sea Investing’s Substack. In this article, we will summarize the bulls’ thesis on AZN.
AstraZeneca PLC (AZN) Announces Positive Results From a Prespecified Interim Analysis of the I CAN Phase III Trial
AstraZeneca PLC (NYSE:AZN) is one of the best stem cell therapy stocks to buy. AstraZeneca PLC (NYSE:AZN) announced on April 21 that positive high-level results from a prespecified interim analysis of...
Hedge Fund Resource Center